Authors:
Saito, H
Ebinuma, H
Satoh, I
Miyaguchi, S
Tada, S
Iwabuchi, N
Kumagai, N
Tsuchimoto, K
Morizane, T
Ishii, H
Citation: H. Saito et al., Immunological and virological predictors of outcome during interferon-alpha therapy of chronic hepatitis C, J VIRAL HEP, 7(1), 2000, pp. 64-74
Authors:
Toda, K
Kumagai, N
Tsuchimoto, K
Inagaki, H
Suzuki, T
Oishi, T
Atsukawa, K
Saito, H
Morizane, T
Hibi, T
Ishii, H
Citation: K. Toda et al., Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis, J GASTRO, 35(3), 2000, pp. 214-220
Authors:
Atsukawa, K
Saito, H
Ebinuma, H
Morizane, T
Takahashi, M
Ohishi, T
Kumagai, N
Tsuchimoto, K
Ishii, H
Citation: K. Atsukawa et al., Reduced in vitro immunoglobulin secretion from peripheral blood mononuclear cells in responders to high-dose interferon-alpha 2b treatment for chronic hepatitis C, HEP-GASTRO, 47(36), 2000, pp. 1685-1690
Authors:
Miyakawa, H
Kikazawa, E
Abe, K
Kikuchi, K
Fujikawa, H
Matsushita, M
Kawaguchi, N
Morizane, T
Ohya, K
Kako, M
Citation: H. Miyakawa et al., Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases, AUTOIMMUN, 30(2), 1999, pp. 107-114
Authors:
Tsunematsu, S
Iwabuchi, N
Kumagai, N
Tsuchimoto, K
Morizane, T
Ishii, H
Citation: S. Tsunematsu et al., Amount of CD4+/CD28+or CD4+/CD26+lymphocytes in peripheral blood in patients with chronic hepatitis C during interferon-beta therapy, INT J IMM T, 15(2), 1999, pp. 73-78